<DOC>
	<DOCNO>NCT00195637</DOCNO>
	<brief_summary>This study evaluate patient Hereditary Inclusion Body Myopathy ( HIBM ) examine effect immune globulin ( IG ) treatment muscle muscle function . HIBM progressive neuromuscular disease begin early adulthood , primarily affect limb muscle . It result mutation gene responsible produce sialic acid , sugar normally find surface certain protein , include alpha-dystroglycan , involved muscle function . Some patient HIBM decrease sialic acid alpha-dystroglycan protein , may cause muscle weakness . IG protein blood carry large amount sialic acid . This study administer IG patient HIBM determine sialic acid IG take muscle cell patient restore muscle function . Four patient HIBM admit study NIH Clinical Center evaluation IG treatment . The evaluation last 1 month . After complete baseline study ( see ) , patient receive two intravenous dos immune globulin ( day 6 7 ) , follow measurement muscle strength 2 day later ( day 9 ) . They receive additional IG infusion day 13 , 20 , 27 . A final set test perform day 29 . Patients may leave hospital pas study do . A patient 's initial evaluation include : - History physical examination , neurological examination , eye examination - 24-hour urine collection - Blood test two separate day - Photographs show extent muscle affect - Chest x-ray , electrocardiogram ( EKG ) , echocardiogram - Two muscle biopsy , one one IG treatment . For procedure , small sample muscle tissue surgically remove examination microscope . - Muscle strength endurance testing , include follow : The patient use pulley attach machine measure strength 24 different muscle group The patient walk 6 minute perform exercise To evaluate swallowing , patient swallow thick substance call barium The patient 's tongue strength measure use specialized instrument . -Magnetic resonance imaging ( MRI ) muscle thigh calf : MRI use magnetic field radio wave produce detailed picture organ tissue . During scan , subject lie table narrow cylinder contain magnetic field , wear ear plug muffle loud noise occur electrical switch magnetic field . He speak staff member via intercom system time procedure . The neurological muscle strength endurance evaluation repeat study day 9 29 .</brief_summary>
	<brief_title>Intravenous Immune Globulin Treat Hereditary Inclusion Body Myopathy</brief_title>
	<detailed_description>Hereditary Inclusion Body Myopathy ( HIBM ) autosomal recessive neuromuscular disorder onset early adulthood progressive muscle weakness lead death within 2-3 decade . The causative gene , GNE , cod bifunctional enzyme UDP N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase ; mutation GNE allele , either epimerase kinase domain , result HIBM . Members Iranian-Jewish isolate homozygous specific kinase domain mutation . The epimerase kinase enzymes catalyze first second , rate-limiting step synthesis sialic acid , also call N-acetylneuraminic acid . This charged sugar provide terminal carbohydrate variety N-linked O-linked glycoprotein mediate cell-cell protein-protein interaction . The cell HIBM patient produce reduced amount free sialic acid , evidence decrease sialylation glycoprotein , include critical muscle protein call alpha-dystroglycan ( alpha-DG ) . This protein , decorate O-mannosyl glycans contain terminal sialic acid , part dystrophin-glycoprotein complex responsible link inside muscle cell extracellular matrix . In HIBM , improper sialylation alpha-DG , due decrease sialic acid synthesis , consider impair interaction alpha-DG protein ligand , result gradual deterioration muscle cell . In open-label pilot study , propose provide free sialic acid muscle cell HIBM patient intravenous infusion immune globulin ( IvIg ) , glycoprotein contain 8 microlitermoles sialic acid per gram prove safety profile FDA-approved drug . Four subject treat - two homozygous Iranian Jewish kinase domain mutation , two least one epimerase domain mutation . IvIg give load dose 1 gram per kilogram body weight two consecutive day , follow next 3 week maintenance dose 400 milligram per kilogram body weight . This maintain serum immune globulin level high enough achieve continuous breakdown large amount glycoprotein , provide free sialic acid blood , scavenger cell , hope , muscle cell . Muscle biopsy strength test perform infusion . The primary clinical outcome parameter muscle strength , gauge mechanically Quantitative Muscle Testing manually physical examination perform neurologist . Secondary outcome parameter employ 6-minute walk test , grip strength , tongue strength , swallow duration , Human Activity Profile questionnaire . Staining muscle beta-DG sialic acid O-mannosyl glycans provide histological outcome parameter . An improvement muscle strength alpha-DG sialylation prompt control trial efficacy treatment .</detailed_description>
	<mesh_term>Muscular Diseases</mesh_term>
	<mesh_term>Distal Myopathies</mesh_term>
	<mesh_term>Immunoglobulins , Intravenous</mesh_term>
	<mesh_term>gamma-Globulins</mesh_term>
	<mesh_term>Rho ( D ) Immune Globulin</mesh_term>
	<mesh_term>Immunoglobulins</mesh_term>
	<mesh_term>Antibodies</mesh_term>
	<criteria>INCLUSION CRITERIA : Age 1870 year , either gender Diagnosis HIBM base upon consistent clinical course plus either convincing muscle histology identification GNE gene mutation Ability travel NIH Clinical Research Center admissions EXCLUSION CRITERIA : Age le than18 great 70 , pregnancy Previous adverse reaction IvIg resolve acetaminophen benadryl treatment History myocardial infarction , stroke , kidney disease Psychiatric illness neurological disease interfere compliance communication health care personnel Current malignancy Uncontrolled hypertension ( blood pressure great than180 systolic great 95 diastolic ) Electrocardiogram change indicative myocardial infarction , arrhythmia , tachycardia , bradycardia , leave bundle branch block Chest radiographic abnormality , include infiltrate , mass , congestive heart failure , embolism , atelectasis Serum potassium le 3.0 mEq/L Serum creatinine great 2.0 mg/dL SGPT SGOT great 70 U/L Hemoglobin le 10.0 g/dL Platelets le than100 k/mm ( 3 ) WBC le 3.0 k/microliters ESR great than100 mm/h</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>May 4, 2016</verification_date>
	<keyword>GNE Gene</keyword>
	<keyword>Alpha-Dystroglycan</keyword>
	<keyword>Sialic Acid</keyword>
	<keyword>Glycosylation</keyword>
	<keyword>Dystroglycanopathy</keyword>
	<keyword>Hereditary Inclusion Body Myopathy</keyword>
	<keyword>Immune Globulin</keyword>
	<keyword>HIBM</keyword>
</DOC>